Terms: = Pancreatic cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Diagnosis
9 results:
1. Trends in access to minimally invasive pancreaticoduodenectomy for pancreatic cancers.
Seldomridge AN; Rasic G; Papageorge MV; Ng SC; de Geus SWL; Woods AP; McAneny D; Tseng JF; Sachs TE
HPB (Oxford); 2024 Mar; 26(3):333-343. PubMed ID: 38087704
[TBL] [Abstract] [Full Text] [Related]
2. The Diagnostic and Prognostic Value of miR-155 in cancers: An Updated Meta-analysis.
Wu Y; Hong Q; Lu F; Zhang Z; Li J; Nie Z; He B
Mol Diagn Ther; 2023 May; 27(3):283-301. PubMed ID: 36939982
[TBL] [Abstract] [Full Text] [Related]
3. pancreatic steatosis on computed tomography is an early imaging feature of pre-diagnostic pancreatic cancer: A preliminary study in overweight patients.
Hoogenboom SA; Bolan CW; Chuprin A; Raimondo MT; van Hooft JE; Wallace MB; Raimondo M
Pancreatology; 2021 Mar; 21(2):428-433. PubMed ID: 33485792
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of morphological features in lymph node metastasis between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomas.
Takahashi D; Kojima M; Morisue R; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Gotohda N; Ikeda M; Ochiai A
Pancreatology; 2020 Jul; 20(5):936-943. PubMed ID: 32553561
[TBL] [Abstract] [Full Text] [Related]
5. Estimates of Overall Survival in Patients With cancer Receiving Different Treatment Regimens: Emulating Hypothetical Target Trials in the Surveillance, Epidemiology, and End Results (SEER)-Medicare Linked Database.
Petito LC; García-Albéniz X; Logan RW; Howlader N; Mariotto AB; Dahabreh IJ; Hernán MA
JAMA Netw Open; 2020 Mar; 3(3):e200452. PubMed ID: 32134464
[TBL] [Abstract] [Full Text] [Related]
6. [Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine chemotherapy: clinical characteristics of long-term survivors].
An SG; Kim DU; Song GA; Jang AL
Korean J Gastroenterol; 2014 Dec; 64(6):356-63. PubMed ID: 25530587
[TBL] [Abstract] [Full Text] [Related]
7. Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions.
Ince AT; Yıldız K; Baysal B; Danalıoğlu A; Kocaman O; Tozlu M; Gangarapu V; Sarbay Kemik A; Uysal Ö; Şentürk H
Turk J Gastroenterol; 2014 Apr; 25(2):162-9. PubMed ID: 25003676
[TBL] [Abstract] [Full Text] [Related]
8. Cost-utility estimations of palliative care in patients with pancreatic adenocarcinoma: a retrospective analysis.
Ljungman D; Hyltander A; Lundholm K
World J Surg; 2013 Aug; 37(8):1883-91. PubMed ID: 23519293
[TBL] [Abstract] [Full Text] [Related]
9. Early detection of pancreatic cancer following the diagnosis of chronic pancreatitis.
Talamini G; Bassi C; Falconi M; Sartori N; Pasetto M; Salvia R; Di Francesco V; Frulloni L; Vaona B; Bovo P; Pederzoli P; Cavallini G
Digestion; 1999; 60(6):554-61. PubMed ID: 10545726
[TBL] [Abstract] [Full Text] [Related]
